Sageworth Trust Company of South Dakota’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-10
Closed -$1K 463
2022
Q2
$1K Hold
10
﹤0.01% 492
2022
Q1
$1K Sell
10
-65
-87% -$6.5K ﹤0.01% 533
2021
Q4
$7K Buy
+75
New +$7K 0.01% 459